Revolution Medicines Inc (RVMD)
38.33
+0.16
(+0.42%)
USD |
NASDAQ |
May 31, 16:00
38.33
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Free Cash Flow: -457.88M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -457.88M |
December 31, 2023 | -358.30M |
September 30, 2023 | -300.08M |
June 30, 2023 | -252.32M |
March 31, 2023 | -242.32M |
December 31, 2022 | -235.22M |
September 30, 2022 | -211.00M |
June 30, 2022 | -192.78M |
March 31, 2022 | -169.93M |
Date | Value |
---|---|
December 31, 2021 | -153.71M |
September 30, 2021 | -139.46M |
June 30, 2021 | -130.13M |
March 31, 2021 | -115.20M |
December 31, 2020 | -103.00M |
September 30, 2020 | -88.96M |
June 30, 2020 | -76.21M |
March 31, 2020 | -67.88M |
December 31, 2019 | -52.20M |
Free Cash Flow Range, Past 5 Years
-457.88M
Minimum
Mar 2024
-52.20M
Maximum
Dec 2019
-185.92M
Average
-161.82M
Median
Free Cash Flow Benchmarks
Day One Biopharmaceuticals Inc | -170.60M |
Iovance Biotherapeutics Inc | -405.08M |
TRACON Pharmaceuticals Inc | 6.136M |
Beam Therapeutics Inc | -169.28M |
Zentalis Pharmaceuticals Inc | -211.14M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -160.56M |
Cash from Investing (Quarterly) | -247.97M |
Cash from Financing (Quarterly) | 0.81M |
Free Cash Flow Per Share (Quarterly) | -0.9939 |
Free Cash Flow Yield | -9.15% |